About VKT Pharma
VKT Pharma is a company based in Hyderabad (India) founded in 2009. It operates as a B2B and Partnerships. VKT Pharma has raised $1.07 million across 1 funding round from investors including Sms Pharmaceuticals. The company has 238 employees as of March 31, 2023. VKT Pharma offers products and services including Formulated Products, Pellets, and OSD. VKT Pharma operates in a competitive market with competitors including Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
- Headquarter Hyderabad, India
- Employees 238 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Vkt Pharma Private Limited
- Date of Incorporation 31 May, 2006
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$3.84 M (USD)-20.39as on Mar 31, 2023
-
Net Profit
-$3.6 M (USD)-93.31as on Mar 31, 2023
-
EBITDA
-$2.7 M (USD)-450.76as on Mar 31, 2023
-
Total Equity Funding
$1.07 M (USD)
in 1 rounds
-
Latest Funding Round
$1.07 M (USD), Seed
Mar 27, 2017
- Investors
-
Employee Count
238
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VKT Pharma
VKT Pharma offers a comprehensive portfolio of products and services, including Formulated Products, Pellets, and OSD.
Develops and produces solid dosage forms for generic drugs.
Manufactures modified release pellets for various therapeutics.
Handles production of tablets and capsules for global markets.
Funding Insights of VKT Pharma
VKT Pharma has successfully raised a total of $1.07M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.07 million completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $1.1M
-
First Round
First Round
(27 Mar 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Seed - VKT Pharma | Valuation |
investors |
Investors in VKT Pharma
VKT Pharma has secured backing from 1 investor. Prominent investors backing the company include Sms Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Active pharmaceutical ingredients and intermediates are manufactured by SMS Pharmaceuticals.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VKT Pharma
Financial Statements - VKT Pharma
Vkt Pharma Comparisons
Competitors of VKT Pharma
VKT Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Zim Labs, Suzhou Ze Jing Biological Pharmaceutical, Capsugel and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Oral solid drug delivery systems are manufactured and developed.
|
|
| domain | founded_year | HQ Location |
Solid and semisolid dosage forms are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Company developing small molecules & eukaryotic cell based recombinant protein drugs
|
|
| domain | founded_year | HQ Location |
Dosage forms are delivered for preclinical, clinical, and commercial supply.
|
|
| domain | founded_year | HQ Location |
CDMO manufacturing solid drugs
|
|
| domain | founded_year | HQ Location |
Product development, manufacturing and packaging services
|
Latest news on Vkt Pharma
Frequently Asked Questions about VKT Pharma
VKT Pharma was founded in 2009 and raised its 1st funding round 8 years after it was founded.
VKT Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
VKT Pharma is a funded company, having raised a total of $1.07M across 1 funding round to date. The company's 1st funding round was a Seed of $1.07M, raised on Mar 27, 2017.
As of Mar 31, 2023, the latest employee count at VKT Pharma is 238.
Annual revenue of VKT Pharma is $3.84M as on Mar 31, 2023.
VKT Pharma is a vertically integrated pharmaceutical company that manages the full value chain from research and development to manufacturing and delivery of solid dosage forms like tablets and pellets. Based in India, it operates in over 10 countries through alliances and partnerships, focusing on generic drugs and novel delivery systems. The company emphasizes quality compliance and regulatory standards in therapeutic segments to serve global markets.
VKT Pharma's top competitors include Inventia Healthcare, Zim Labs and Lotus.
VKT Pharma offers Formulated Products, Pellets, and OSD.
VKT Pharma has 1 investor. Key investors include Sms Pharmaceuticals.